459 related articles for article (PubMed ID: 28053234)
21. Intracellular concentrations of Ca(2+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/CD86 interactions in CD4(+) T lymphocytes.
Ahmed A; Mukherjee S; Nandi D
Immunology; 2009 Mar; 126(3):363-77. PubMed ID: 18710402
[TBL] [Abstract][Full Text] [Related]
22. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
Vogel I; Verbinnen B; Van Gool S; Ceuppens JL
J Immunol; 2016 Jul; 197(2):533-40. PubMed ID: 27288533
[TBL] [Abstract][Full Text] [Related]
23. Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.
Marangoni F; Zhakyp A; Corsini M; Geels SN; Carrizosa E; Thelen M; Mani V; Prüßmann JN; Warner RD; Ozga AJ; Di Pilato M; Othy S; Mempel TR
Cell; 2021 Jul; 184(15):3998-4015.e19. PubMed ID: 34157302
[TBL] [Abstract][Full Text] [Related]
24. Accessory Molecule and Costimulation Requirements for CD4 T Cell Response.
Croft M; Dubey C
Crit Rev Immunol; 2017; 37(2-6):261-290. PubMed ID: 29773023
[TBL] [Abstract][Full Text] [Related]
25. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
26. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
27. CD4(+) T-cell activation is differentially modulated by bacteria-primed dendritic cells, but is generally down-regulated by n-3 polyunsaturated fatty acids.
Brix S; Lund P; Kjaer TM; Straarup EM; Hellgren LI; Frøkiaer H
Immunology; 2010 Mar; 129(3):338-50. PubMed ID: 19909377
[TBL] [Abstract][Full Text] [Related]
28. CTLA-4Ig: uses and future directions.
Ben-Shoshan M
Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):132-42. PubMed ID: 19519590
[TBL] [Abstract][Full Text] [Related]
29. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
30. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
32. CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease.
Pinto BF; Medeiros NI; Teixeira-Carvalho A; Eloi-Santos SM; Fontes-Cal TCM; Rocha DA; Dutra WO; Correa-Oliveira R; Gomes JAS
Front Immunol; 2018; 9():454. PubMed ID: 29599775
[TBL] [Abstract][Full Text] [Related]
33. B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells.
Ertelt JM; Buyukbasaran EZ; Jiang TT; Rowe JH; Xin L; Way SS
J Leukoc Biol; 2013 Aug; 94(2):367-76. PubMed ID: 23744647
[TBL] [Abstract][Full Text] [Related]
34. Blockade of CD80/CD86-CD28 co-stimulation augments the inhibitory function of peptide antigen-specific regulatory T cells.
Maehara Y; Takeda K; Tsuji-Yogo K; Morimoto K; Harada M; Kuriyama K; Hirota S; Yagita H; Okumura K; Uchida K
Biomed Res; 2024; 45(3):115-123. PubMed ID: 38839354
[TBL] [Abstract][Full Text] [Related]
35. CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement.
Wang CJ; Heuts F; Ovcinnikovs V; Wardzinski L; Bowers C; Schmidt EM; Kogimtzis A; Kenefeck R; Sansom DM; Walker LS
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):524-9. PubMed ID: 25548162
[TBL] [Abstract][Full Text] [Related]
36. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4.
Wing JB; Ise W; Kurosaki T; Sakaguchi S
Immunity; 2014 Dec; 41(6):1013-25. PubMed ID: 25526312
[TBL] [Abstract][Full Text] [Related]
38. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
[TBL] [Abstract][Full Text] [Related]
39. Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics.
Zenke S; Palm MM; Braun J; Gavrilov A; Meiser P; Böttcher JP; Beyersdorf N; Ehl S; Gerard A; Lämmermann T; Schumacher TN; Beltman JB; Rohr JC
Immunity; 2020 Feb; 52(2):313-327.e7. PubMed ID: 32049052
[TBL] [Abstract][Full Text] [Related]
40. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
